Recombinant Human MCEE Protein: Protocol & Application Guide

Recombinant Human MCEE Protein is a bacterially or recombinantly expressed form of methylmalonyl-CoA epimerase designed to support enzyme activity assays, metabolic pathway studies, and protein interaction experiments in research settings.

Product Name

Recombinant Human MCEE Protein

SKU

rp369629

Protein Function

Catalyzes the interconversion of (R)- and (S)-methylmalonyl-CoA, a key step in propionate metabolism and the catabolism of odd-chain fatty acids and certain amino acids.

Recommended Storage

Store at -80°C for long-term storage; avoid repeated freeze-thaw cycles.

Reconstitution

Reconstitute in sterile deionized water or appropriate buffer (e.g., PBS) to the desired working concentration.

Typical Applications

Enzyme activity assays, SDS-PAGE/Western blot validation, metabolic pathway research, protein-protein interaction studies.

Background: MCEE Biology and Research Significance

Methylmalonyl-CoA epimerase (MCEE) is a mitochondrial enzyme encoded by the MCEE gene. It catalyzes the reversible epimerization of (R)-methylmalonyl-CoA to (S)-methylmalonyl-CoA, an obligate intermediate step in the conversion of propionyl-CoA to succinyl-CoA via methylmalonyl-CoA mutase (MUT). This pathway is essential for the catabolism of odd-chain fatty acids, the amino acids valine, isoleucine, methionine, and threonine, as well as cholesterol side chains.

Deficiency in MCEE activity has been associated with mild methylmalonic acidemia (MMAemia), a metabolic disorder characterized by elevated methylmalonic acid in blood and urine. Research into MCEE is therefore relevant to inborn errors of metabolism, mitochondrial biology, and potential therapeutic target identification. Recombinant Human MCEE Protein (rp369629) enables researchers to study enzyme kinetics, screen inhibitors or activators, and investigate protein interactions in a controlled, cell-free system.

Reagents, Equipment, and Safety Considerations

Reagents required:

• Recombinant Human MCEE Protein (rp369629, Aladdin Scientific)
• Sterile deionized water or phosphate-buffered saline (PBS, pH 7.4)
• Appropriate assay buffer (e.g., 50 mM Tris-HCl, pH 7.5, 100 mM NaCl)
• Protease inhibitor cocktail (optional, for extended incubations)
• Carrier protein (e.g., 0.1% BSA) if diluting to low concentrations

Equipment required:

• Microcentrifuge tubes (low-binding, 0.5–1.5 mL)
• Micropipettes and calibrated tips
• Vortex mixer
• Benchtop microcentrifuge
• -80°C freezer and dry ice for handling
• Spectrophotometer or plate reader (for enzyme activity assays)

Safety: Handle all recombinant proteins following institutional biosafety guidelines. Wear appropriate PPE (gloves, lab coat, eye protection). The protein is derived from a human gene; treat as a potential biohazard in accordance with local regulations. Avoid aerosol generation during reconstitution.

Step-by-Step Protocol: Reconstitution and Working Solution Preparation

Step 1 — Thawing: Remove the vial of Recombinant Human MCEE Protein (rp369629) from -80°C storage. Allow it to thaw slowly on ice (approximately 10–15 minutes). Do not thaw at room temperature or in a water bath, as rapid temperature changes can reduce protein activity.

Step 2 — Brief centrifugation: Briefly centrifuge the vial (1,000–2,000 × g, 30 seconds) to collect any condensed liquid from the walls and cap before opening.

Step 3 — Reconstitution: Add an appropriate volume of sterile deionized water or PBS (pH 7.4) to the vial. Gently pipette up and down 5–10 times to mix. Avoid vigorous vortexing, which can denature the protein. The final concentration should be determined based on the specific lot concentration provided on the Certificate of Analysis (CoA).

Step 4 — Aliquoting: Prepare single-use aliquots immediately after reconstitution to prevent activity loss from repeated freeze-thaw cycles. Use low-binding microcentrifuge tubes. Add 0.1% BSA to aliquots intended for long-term storage at dilute concentrations to stabilize the protein.

Step 5 — Storage of aliquots: Store aliquots at -80°C. For short-term use (up to 1 week), aliquots may be stored at -20°C. Avoid storing the working solution at 4°C for more than 24–48 hours.

Step 6 — Preparation of working concentration: Dilute the reconstituted protein to the desired working concentration using the appropriate assay buffer immediately before use. Mix gently by pipetting; do not vortex.

Application Notes: Enzyme Activity Assay and Quality Verification

Enzyme Activity Assay: Recombinant Human MCEE Protein can be used in coupled or direct assays to measure the epimerization of methylmalonyl-CoA. A typical coupled spectrophotometric assay monitors the conversion of (R)-methylmalonyl-CoA to (S)-methylmalonyl-CoA, which is subsequently acted upon by methylmalonyl-CoA mutase (MUT) in the presence of adenosylcobalamin (AdoCbl). Reaction progress can be monitored at 232 nm (thioester bond absorbance) or by using HPLC-based substrate depletion methods.

Recommended assay buffer: 50 mM potassium phosphate or Tris-HCl, pH 7.4–7.5, supplemented with 1 mM DTT to maintain a reducing environment and preserve cysteine residues critical for activity.

SDS-PAGE and Western Blot Verification: Prior to functional assays, verify protein integrity by running a small aliquot (1–2 µg) on a reducing SDS-PAGE gel. The expected molecular weight of MCEE monomer is approximately 17–18 kDa. Confirm identity by Western blot using an anti-MCEE antibody or anti-tag antibody if a fusion tag is present (refer to the product CoA for tag information).

Protein-Protein Interaction Studies: Recombinant MCEE Protein is suitable for co-immunoprecipitation (co-IP), pull-down assays, and surface plasmon resonance (SPR) experiments to characterize interactions with binding partners such as MUT and other mitochondrial metabolic enzymes.

Troubleshooting and Best Practices

Low or no enzyme activity: Ensure protein was not subjected to repeated freeze-thaw cycles. Verify that the assay buffer pH is within the optimal range (7.4–7.5). Confirm that reducing agent (DTT or β-mercaptoethanol) is present. Check that substrate (methylmalonyl-CoA) is fresh and properly stored. If using a coupled assay, confirm the auxiliary enzyme (MUT) and cofactor (AdoCbl) are functional.

Protein aggregation or precipitation: If visible precipitation is observed after reconstitution, centrifuge at 10,000 × g for 5 minutes at 4°C and use the supernatant. Aggregation may occur if the protein was thawed too rapidly or stored at suboptimal concentrations. Adding 5–10% glycerol to the storage buffer can improve stability.

Unexpected band size on SDS-PAGE: Ensure a fully reducing sample buffer is used. Recombinant proteins with fusion tags will migrate at a higher apparent molecular weight than the untagged native form. Consult the product CoA for the expected molecular weight of the specific construct used.

Carry-over contamination: Always use dedicated, DNase/RNase-free, low-binding plasticware. Avoid contact with metal surfaces that may oxidize the protein.

Best practices summary: Aliquot upon first thaw; use low-binding tubes; include a reducing agent in all buffers; validate protein integrity before each experimental set; store working aliquots at -80°C.

Frequently asked questions

What is the recommended reconstitution buffer for Recombinant Human MCEE Protein?

Recombinant Human MCEE Protein (rp369629) is best reconstituted in sterile deionized water or PBS (pH 7.4). For functional assays, further dilute into an assay buffer such as 50 mM Tris-HCl or potassium phosphate (pH 7.4–7.5) supplemented with 1 mM DTT. Always refer to the Certificate of Analysis supplied with your specific lot for any lot-specific recommendations.

How should Recombinant Human MCEE Protein be stored to maintain activity?

For long-term storage, keep aliquots at -80°C. Repeated freeze-thaw cycles significantly reduce enzyme activity, so single-use aliquots are strongly recommended. Short-term storage (up to one week) is acceptable at -20°C. Working solutions should not be kept at 4°C for more than 24–48 hours. Adding 0.1% BSA or 5–10% glycerol to dilute preparations can further stabilize the protein.

What are the main research applications of Recombinant Human MCEE Protein?

Recombinant Human MCEE Protein is used primarily in enzyme kinetics and activity assays to study the epimerization of methylmalonyl-CoA in the propionate metabolic pathway. Additional applications include SDS-PAGE and Western blot for protein characterization, protein-protein interaction studies (co-IP, pull-down, SPR), and as a positive control or standard in metabolic disease research related to methylmalonic acidemia.

What molecular weight should I expect when running MCEE on SDS-PAGE?

The human MCEE monomer has a molecular weight of approximately 17–18 kDa. If the recombinant protein carries a purification tag (e.g., His-tag, GST-tag), the apparent molecular weight on SDS-PAGE will be slightly higher. Please consult the Certificate of Analysis for the exact expected molecular weight of the rp369629 construct.

Is Recombinant Human MCEE Protein suitable for use as an antigen for antibody production?

Yes, recombinant proteins such as MCEE are commonly used as immunogens for raising polyclonal or monoclonal antibodies. The high purity of recombinant MCEE protein makes it suitable for immunization and for use as a coating antigen in ELISA-based antibody validation. Confirm purity and endotoxin levels from the Certificate of Analysis before use in animal studies.

References

1. Dobson CM, Wai T, Leclerc D, et al. Identification of the gene responsible for the cblA complementation group of vitamin B12-responsive methylmalonic acidemia based on analysis of prokaryotic gene arrangements. Proc Natl Acad Sci USA. 2002;99(24):15554-15559.
2. Kurczynski TW, Hoppel CL, Goldblatt PJ, et al. Methylmalonyl-CoA epimerase deficiency. J Inherit Metab Dis. 1992;15(5):755-756.
3. Fenton WA, Gravel RA, Rosenblatt DS. Disorders of propionate and methylmalonate metabolism. In: Scriver CR, et al., eds. The Metabolic and Molecular Bases of Inherited Disease. 8th ed. McGraw-Hill; 2001.

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.